Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)--study protocol.

Crowther CA, Middleton PF, Wilkinson D, Ashwood P, Haslam R; MAGENTA Study Group.

BMC Pregnancy Childbirth. 2013 Apr 9;13:91. doi: 10.1186/1471-2393-13-91.

2.

Different treatment regimens of magnesium sulphate for tocolysis in women in preterm labour.

McNamara HC, Crowther CA, Brown J.

Cochrane Database Syst Rev. 2015 Dec 14;(12):CD011200. doi: 10.1002/14651858.CD011200.pub2. Review.

PMID:
26662716
3.

Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.

Doyle LW, Crowther CA, Middleton P, Marret S.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004661. Review. Update in: Cochrane Database Syst Rev. 2009;(1):CD004661.

PMID:
17636771
4.

Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.

Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004661. doi: 10.1002/14651858.CD004661.pub3. Review.

PMID:
19160238
5.

Magnesium sulphate for preventing preterm birth in threatened preterm labour.

Crowther CA, Brown J, McKinlay CJ, Middleton P.

Cochrane Database Syst Rev. 2014 Aug 15;(8):CD001060. doi: 10.1002/14651858.CD001060.pub2. Review.

PMID:
25126773
6.

Calcium channel blockers for inhibiting preterm labour and birth.

Flenady V, Wojcieszek AM, Papatsonis DN, Stock OM, Murray L, Jardine LA, Carbonne B.

Cochrane Database Syst Rev. 2014 Jun 5;(6):CD002255. doi: 10.1002/14651858.CD002255.pub2. Review.

PMID:
24901312
7.

[Neuroprotection for preterm infants with antenatal magnesium sulphate].

Marret S, Ancel PY.

J Gynecol Obstet Biol Reprod (Paris). 2016 Dec;45(10):1418-1433. doi: 10.1016/j.jgyn.2016.09.028. Epub 2016 Oct 28. Review. French.

PMID:
28166926
8.

Magnesium sulphate for women at term for neuroprotection of the fetus.

Nguyen TM, Crowther CA, Wilkinson D, Bain E.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD009395. doi: 10.1002/14651858.CD009395.pub2. Review.

PMID:
23450601
9.

Magnesium supplementation in pregnancy.

Makrides M, Crosby DD, Bain E, Crowther CA.

Cochrane Database Syst Rev. 2014 Apr 3;(4):CD000937. doi: 10.1002/14651858.CD000937.pub2. Review.

PMID:
24696187
10.

Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes.

Stock SJ, Bricker L, Norman JE, West HM.

Cochrane Database Syst Rev. 2016 Jul 12;7:CD008968. doi: 10.1002/14651858.CD008968.pub3. Review.

PMID:
27404120
11.

Cyclo-oxygenase (COX) inhibitors for treating preterm labour.

Reinebrant HE, Pileggi-Castro C, Romero CL, Dos Santos RA, Kumar S, Souza JP, Flenady V.

Cochrane Database Syst Rev. 2015 Jun 5;(6):CD001992. doi: 10.1002/14651858.CD001992.pub3. Review.

PMID:
26042617
12.

Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis.

Conde-Agudelo A, Romero R.

Am J Obstet Gynecol. 2009 Jun;200(6):595-609. doi: 10.1016/j.ajog.2009.04.005. Review.

13.

Magnesium sulphate for preventing preterm birth in threatened preterm labour.

Crowther CA, Hiller JE, Doyle LW.

Cochrane Database Syst Rev. 2002;(4):CD001060. Review. Update in: Cochrane Database Syst Rev. 2014;8:CD001060.

PMID:
12519550
14.

Oxytocin receptor antagonists for inhibiting preterm labour.

Flenady V, Reinebrant HE, Liley HG, Tambimuttu EG, Papatsonis DN.

Cochrane Database Syst Rev. 2014 Jun 6;(6):CD004452. doi: 10.1002/14651858.CD004452.pub3. Review.

PMID:
24903678
15.

Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants.

Spittle A, Orton J, Anderson PJ, Boyd R, Doyle LW.

Cochrane Database Syst Rev. 2015 Nov 24;(11):CD005495. doi: 10.1002/14651858.CD005495.pub4. Review.

PMID:
26597166
16.

Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review.

Doyle LW, Crowther CA, Middleton P, Marret S.

Obstet Gynecol. 2009 Jun;113(6):1327-33. doi: 10.1097/AOG.0b013e3181a60495. Review.

PMID:
19461430
17.

Antenatal magnesium sulfate and neuroprotection.

Doyle LW.

Curr Opin Pediatr. 2012 Apr;24(2):154-9. doi: 10.1097/MOP.0b013e3283504da1. Review.

PMID:
22227787
18.

Planned early delivery versus expectant management of the term suspected compromised baby for improving outcomes.

Bond DM, Gordon A, Hyett J, de Vries B, Carberry AE, Morris J.

Cochrane Database Syst Rev. 2015 Nov 24;(11):CD009433. doi: 10.1002/14651858.CD009433.pub2. Review.

PMID:
26599471
19.

Different magnesium sulphate regimens for neuroprotection of the fetus for women at risk of preterm birth.

Bain E, Middleton P, Crowther CA.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD009302. doi: 10.1002/14651858.CD009302.pub2. Review.

PMID:
22336863
20.

Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour.

Naik Gaunekar N, Raman P, Bain E, Crowther CA.

Cochrane Database Syst Rev. 2013 Oct 31;(10):CD004071. doi: 10.1002/14651858.CD004071.pub3. Review.

PMID:
24173691

Supplemental Content

Support Center